1. Interaction of α-Thymidine Inhibitors with Thymidylate Kinase from Plasmodium falciparum.
- Author
-
Chen MD, Sinha K, Rule GS, and Ly DH
- Subjects
- Antimalarials chemistry, Antimalarials pharmacology, Binding Sites, Enzyme Inhibitors chemistry, Humans, Kinetics, Malaria, Falciparum parasitology, Nucleoside-Phosphate Kinase chemistry, Plasmodium falciparum drug effects, Plasmodium falciparum enzymology, Plasmodium falciparum pathogenicity, Protein Binding, Substrate Specificity, Thymidine antagonists & inhibitors, Enzyme Inhibitors pharmacology, Malaria, Falciparum drug therapy, Nucleoside-Phosphate Kinase antagonists & inhibitors, Thymidine chemistry
- Abstract
Plasmodium falciparum thymidylate kinase (PfTMK) is a critical enzyme in the de novo biosynthesis pathway of pyrimidine nucleotides. N-(5'-Deoxy-α-thymidin-5'-yl)- N'-[4-(2-chlorobenzyloxy)phenyl]urea was developed as an inhibitor of PfTMK and has been reported as an effective inhibitor of P. falciparum growth with an EC
50 of 28 nM [Cui, H., et al. (2012) J. Med. Chem. 55, 10948-10957]. Using this compound as a scaffold, a number of derivatives were developed and, along with the original compound, were characterized in terms of their enzyme inhibition ( Ki ) and binding affinity ( KD ). Furthermore, the binding site of the synthesized compounds was investigated by a combination of mutagenesis and docking simulations. Although the reported compound is indicated to be highly effective in its inhibition of parasite growth, we observed significantly lower binding affinity and weaker inhibition of PfTMK than expected from the reported EC50 . This suggests that significant structural optimization will be required for the use of this scaffold as an effective PfTMK inhibitor and that the inhibition of parasite growth is due to an off-target effect.- Published
- 2018
- Full Text
- View/download PDF